Clinical Trial Update: Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating neoadjuvant intra-tumor double immunotherapy for non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Lung Cancer, Surgery | Phase 2 | Status: RECRUITING